| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PF-543 | CTRPv2 | pan-cancer | AAC | -0.019 | 0.6 |
| mRNA | Axitinib | CTRPv2 | pan-cancer | AAC | -0.017 | 0.6 |
| mRNA | MI-1 | CTRPv2 | pan-cancer | AAC | -0.019 | 0.6 |
| mRNA | BRD-K11533227 | CTRPv2 | pan-cancer | AAC | 0.018 | 0.6 |
| mRNA | carboplatin:etoposide (40:17 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.015 | 0.6 |
| mRNA | vorapaxar | CTRPv2 | pan-cancer | AAC | -0.018 | 0.6 |
| mRNA | Bortezomib | gCSI | pan-cancer | AAC | -0.029 | 0.6 |
| mRNA | B02 | CTRPv2 | pan-cancer | AAC | 0.017 | 0.6 |
| mRNA | NVP-231 | CTRPv2 | pan-cancer | AAC | -0.015 | 0.6 |
| mRNA | 968 | CTRPv2 | pan-cancer | AAC | -0.033 | 0.6 |